2012
ANALYSIS OF MICRO RNAS EXPRESSION IN CELL LINES DERIVED FROM PROSTATE CARCINOMA
HUDCOVÁ, Kristýna, Martina RAUDENSKÁ, Marián HLAVNA, Jaromír GUMULEC, Markéta SZTALMACHOVÁ et. al.Základní údaje
Originální název
ANALYSIS OF MICRO RNAS EXPRESSION IN CELL LINES DERIVED FROM PROSTATE CARCINOMA
Autoři
HUDCOVÁ, Kristýna, Martina RAUDENSKÁ, Marián HLAVNA, Jaromír GUMULEC, Markéta SZTALMACHOVÁ, Veronika TANHÄUSEROVÁ, Petr BABULA, Vojtěch ADAM, René KIZEK a Michal MASAŘÍK
Vydání
12th Workshop of Physical Chemists and Electrochemists, 2012
Další údaje
Jazyk
angličtina
Typ výsledku
Konferenční abstrakt
Obor
Genetika a molekulární biologie
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 3.729 v roce 2011
ISBN
978-80-7375-618-5
ISSN
Klíčová slova česky
miRNA; prostate carcinoma; qRT-PCR
Změněno: 29. 1. 2016 13:35, doc. MUDr. Jaromír Gumulec, Ph.D.
Anotace
V originále
MiRNAs constitute a large class of single-stranded RNA molecules of 19 to 25 nucleotides that are involved in post-transcriptional gene silencing. MiRNAs not only regulate various developmental and physiologic processes but also are involved in cancer development and can play a role as an important biomarkers. The aim of this study was to determinate the expression levels of selected miRNA in the non-tumor PNT1A line in comparison with tumor lines 22Rv1, PC-3, and LNCaP. We used the TaqMan Gene Expression Assays and quantitative RT-PCR. We observed significantly higher (p<0.01) expression of miRNA 23a in all tumor lines compared to non-tumor PNT1A. Significantly higher (p<0.01) expression of miRNA 224 in 22Rv1 line compared to others and significantly higher (p<0.01) expression of miRNA 375 in all tumor lines in comparison with non-tumor PNT1A.